AmerisourceBergen Corp. (NYSE: ABC), Valley Forge, PA, reported sales for the second quarter ended March 31, 2013, of $20.5 billion, an increase of 4.1 percent. Profit increased 5.5 percent to $717 million.
Pharmaceutical Distribution sales were $20.1 billion, an increase of 3 percent compared to the same quarter in the prior year. Operating profit fell 9 percent to $328.6 million.
“During the quarter, we took several steps to enhance the long-term growth prospects for AmerisourceBergen, including the announcement of agreements of sale for AndersonBrecon and our Canadian distribution business, and most significantly, a new strategic long-term relationship with Walgreen Co. and Alliance Boots GmbH,” said Steven Collis, AmerisourceBergen president and CEO.
For the first six months, sales were $41.6 billion, up 4.8 percent. Profit increased 10 percent to $1.4 billion.
“Over the next few quarters, our drug wholesale business will significantly expand as we start servicing all the pharmaceutical products for the largest U.S. drug store chain. Moreover, our global partnership provides an unprecedented platform to innovate by leveraging on each company’s respective strengths,” Collis said.
